News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Events
Medivation, Inc. (MDVN) Announces Participation At Upcoming Investor Conference 12/18/2014
Arch Therapeutics To Present At The Biotech Showcase(TM) 2015 Conference On January 14th 2015 12/18/2014
Biothera Participates In Cancer Research UK Combinations Alliance 12/18/2014
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update At 2015 Biotech Showcase In San Francisco 12/18/2014
Astellas To Present At J.P. Morgan Healthcare Conference 12/18/2014
Abbott Laboratories (ABT) To Present At J.P. Morgan Healthcare Conference 12/18/2014
Anavex Life Sciences Corp. (AVXL.OB) To Present At Biotech Showcase 2015 In San Francisco 12/18/2014
Quintiles, Inc. (Q) CEO Tom Pike To Present At J.P. Morgan Healthcare Conference 12/17/2014
CureMark CEO Delivers Keynote Speech At Epigenetics Conference 12/17/2014
Synageva BioPharma (GEVA) To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Monday, January 12, 2015 at 9:00 a.m. PST 12/17/2014
Mylan Inc. (MYL) To Present At The J.P. Morgan 33rd Annual Healthcare Conference 12/17/2014
Cardio3 BioSciences Will Be Present At ODDO Midcap Forum 12/17/2014
MediGene AG (MDGEF.PK) To Participate In Three International Conferences In January 12/17/2014
Eli Lilly (LLY) Sets Dates And Conference Calls For 2015 Financial Guidance And Fourth-Quarter 2014 Financial Results 12/16/2014
Macrophage Therapeutics Release: Data Presented By Independent Academic Collaborators Demonstrate Ability Of Novel Manocept™ Immunotherapy To Kill Activated Macrophages From KS Patients 12/16/2014
Paris, France Will Host Biotechnology Industry Organization (BIO)-Europe Spring 2015 International Life Science Partnering Conference 12/16/2014
Pfizer (PFE) Invites Public To View And Listen To Webcast Of January 27 Conference Call With Analysts 12/16/2014
More Than 150 Companies Expected To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 12/16/2014
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentation At The 33rd Annual J.P. Morgan Healthcare Conference 12/16/2014
Valeant (VRX) To Hold Conference Call To Announce 2015 Financial Guidance 12/16/2014
Aldeyra Therapeutics (ALDX) Abstract Accepted At 2015 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting 12/16/2014
Harvard Bioscience Inc. (HBIO) To Present At Inaugural Equities.Com Small-Cap Stars Conference At The NASDAQ Marketsite In New York City On December 18, 2014 12/16/2014
ImmunoGen, Inc. (IMGN) Announces Webcast Of Presentation At The 33rd Annual J.P. Morgan Healthcare Conference 12/15/2014
Cardio3 BioSciences To Address American Institutional Investors In January At J.P. Morgan Healthcare Conference 12/15/2014
Macrophage Therapeutics To Present Data Supporting Potential For Breakthrough With Manocept™ In Immunotherapy 12/15/2014
Dicerna Pharmaceuticals (DRNA) R&D Update Webcast Reminder 12/15/2014
8th Annual OneMedForum San Francisco, 1/12-13/15, Announces First Group Of Presenting Companies 12/15/2014
BioTime (BTX) To Host Investor And Analyst Day On December 15, 2014 12/15/2014
PCT, A NeoStem, Inc. Company, Presented Lovo® Cell Processing System Data At IBC Life Sciences' Commercialization Of Cell, Gene & Immunotherapies Conference 12/15/2014
Karyopharm Therapeutics (KPTI) Announces Addition To The NASDAQ Biotechnology Index 12/15/2014
ZS Pharma (ZSPH) To Ring The Nasdaq Stock Market Opening Bell 12/15/2014
Data To Be Presented At 2014 San Antonio Breast Cancer Symposium Demonstrate Immune-Stimulatory Properties Of Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab In Models Of Breast Cancer 12/12/2014
Regen BioPharma Presented Novel Therapeutic Target For Leukemia And Myelodysplastic Syndrome At The American Society of Hematology Annual Meeting 12/12/2014
GeoVax Labs Inc. (GOVX.OB)'s Chief Scientific Officer Invited To Present At Dubai Scientific Conference 12/12/2014
Janssen Research & Development Release: Data From The EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented At San Antonio Breast Cancer Symposium 12/12/2014
Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium 12/12/2014
OvaScience (OVAS) To Host Investor Day 12/12/2014
Catalent, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference 12/12/2014
The Association for Molecular Pathology Closes Out 2014 Annual Meeting With Record-Level Attendance 12/12/2014
Oppenheimer's 25th Annual Healthcare Conference Provides Investors With Access To Public And Private Healthcare Companies 12/12/2014
Biotech-Cluster BioRN Cluster Management GmbH Leads Innolife Consortium To Success In The Competition Healthy Living And Active Ageing Of The European Institute For Innovation And Technology (EIT) 12/12/2014
Northwest Biotherapeutics (NWBO) Recaps 2014 Progress, Provides Dcvax-Direct Trial Update At Oppenheimer's 25th Annual Healthcare Conference 12/12/2014
Halozyme Therapeutics, Inc. (HALO) Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting 12/12/2014
Synta Pharmaceuticals (SNTA) Announces Presentation Of Results From An Investigator-Sponsored Phase 1 Trial Of Ganetespib In HER2+ Metastatic Breast Cancer At The 2014 San Antonio Breast Cancer Symposium 12/12/2014
Nektar Therapeutics (CA) (NKTR) Presents Data On Target-Specific Biomarkers From Circulating Tumor Cell Sub-Study Of Phase 3 BEACON Study Of Etirinotecan Pegol (NKTR-102) In Patients With Advanced Breast Cancer 12/12/2014
Auxilium Pharmaceuticals (AUXL) Announces Date For Special Meeting Of Stockholders 12/12/2014
Merrimack Pharmaceuticals Inc. (MACK) Presents Research On Innovative Pipeline For Patients With Breast Cancer At The 2014 San Antonio Breast Cancer Symposium 12/12/2014
Amgen (AMGN) And AstraZeneca PLC (AZN) To Present Results From Phase 3 AMAGINE-1 Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 12/12/2014
ChemoCentryx, Inc. (CCXI)To Host Conference Call On Friday, December 12, 2014 To Discuss Top-Line Phase 2 Results In Patients With Diabetic Nephropathy With CCX140, An Orally Administered CCR2 Inhibitor 12/12/2014
SLAS Partners With Artel To Develop New “Liquid Handling Essentials” Short Course For SLAS2015 12/11/2014
Camargo Pharmaceutical Services Release: Israel Seminar Highlights Best Strategies For Developing New Products In Growing Market 12/11/2014
Camargo Pharmaceutical Services Release: Israel Seminar Highlights Best Strategies For Developing New Products In Growing Market 12/11/2014
Verastem, Inc. (VSTM) Presents Data At The 2014 San Antonio Breast Cancer Symposium 12/11/2014
Nordic Nanovector To Present At DNB Markets 5th Annual Health Care Conference Today 12/11/2014
MabVax Therapeutics, Inc. Selected To Make Corporate Presentation At January 2015 BIOTECH Showcase 12/11/2014
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting 12/11/2014
ANI Pharmaceuticals, Inc. Presents At Oppenheimer 25th Annual Healthcare Conference 12/11/2014
IGI Laboratories, Inc. To Present At 25th Annual Oppenheimer Healthcare Conference On December 11, 2014 12/11/2014
Sienna Labs To Present At The 2nd Annual Dermatology Summit In San Francisco 12/11/2014
Galena Biopharma  (GALE) Presents HER2 Screening Data Including Preliminary Leica Bond Oracle™ Results From the Phase 3 NeuVax™ (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS) 12/11/2014
Radius (RDUS) Presents RAD1901 Data At 2014 San Antonio Breast Cancer Symposium 12/11/2014
Caris Life Sciences Presents Two Studies Demonstrating Utility Of Tumor Profiling: Likelihood Of Response To Immunotherapeutics In HER2-Positive Breast Cancer And The Largest Case Series Comparing Male Breast Cancer To Female Breast Cancer Patients 12/11/2014
Epigenomics AG To Present At Oppenheimer 25th Annual Healthcare Conference 12/10/2014
REMINDER: Theravance Biopharma To Host Investor And Analyst Day On December 12th 12/10/2014
New Data At American Society of Hematology 2014 Highlight Progress Of Pfizer (PFE)’s Growing Portfolio In Blood Cancers 12/10/2014
Merck Announces Positive Data Investigating The Use Of Pembrolizumab In Patients With Advanced Triple-Negative Breast Cancer At 2014 San Antonio Breast Cancer Symposium 12/10/2014
HEALTHSOUTH To Present At The 33rd Annual J.P. Morgan 2015 Healthcare Conference 12/10/2014
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014
VBI To Present At The Equities.Com Small-Cap Stars Conference 12/10/2014
Biscayne Pharmaceuticals Presents Data At 2014 San Antonio Breast Cancer Symposium Further Confirming The Relevance Of Its GHRH Target In Cancer 12/9/2014
Acetylon Pharmaceuticals Presents Positive Preclinical Data On Selective HDAC1/2 Inhibition For The Treatment Of Sickle Cell Disease/?-Thalassemia 12/9/2014
Dynavax Technologies Corporation (DVAX) Announces Webcast Of R&D Day 12/9/2014
Arno Therapeutics To Present Data Further Validating Diagnostic Development Of CDX For Onapristone At San Antonio Breast Cancer Symposium 2014 12/9/2014
BioMarin Pharmaceutical Inc. (BMRN) To Highlight Breadth Of Innovative Development Pipeline At Analyst And Investor Day On December 10th In New York 12/9/2014
Prothena Corporation plc To Present At The Oppenheimer 25th Annual Healthcare Conference In New York 12/9/2014
Biscayne Pharmaceuticals Presents Data At 2014 San Antonio Breast Cancer Symposium Further Confirming The Relevance Of Its GHRH Target In Cancer 12/9/2014
Infinity Pharmaceuticals Inc. (INFI) Reports New Results From Phase 1 Study Of Investigational Oncology Compound Duvelisib At The American Society of Hematology Annual Meeting 12/9/2014
Karyopharm Therapeutics (KPTI) Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At American Society of Hematology 2014 Annual Meeting 12/9/2014
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS At American Society of Hematology Annual Meeting 12/9/2014
Karyopharm Therapeutics (KPTI) Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At American Society of Hematology 2014 Annual Meeting 12/9/2014
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 56th American Society of Hematology Annual Meeting 12/9/2014
Lexicon Pharmaceuticals, Inc. (LXRX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/9/2014
Transition Therapeutics Inc. (TTH.TO) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/9/2014
MediWound (MDWD) To Present At Oppenheimer 25th Annual Healthcare Conference 12/9/2014
17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference To Highlight Industry Financing, Current Policy Trends And The 2015 Market Outlook 12/9/2014
NeuroMetrix, Inc. (NURO) To Participate In The Benchmark Micro Cap Discovery Conference 12/9/2014
Aptose Biosciences Presents APTO-253 Preclinical Data At 56th American Society of Hematology Annual Meeting 12/9/2014
Amgen (AMGN) Presents Data From Pivotal Phase 2 Study Of BLINCYTO (blinatumomab) Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia 12/9/2014
Edwards Lifesciences (EW) Outlines Growth Strategy At Annual Investor Conference 12/8/2014
ContraFect Corporation (CFRXU) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014
Sarah Cannon Research Institute Investigators To Present 16 Abstracts At San Antonio Breast Cancer Symposium 12/8/2014
Clinovo Presents Its Cloud-Based EDC System ClinCapture At The San Diego Clinical Research Network Event In San Diego 12/8/2014
Actavis (ACT) To Present Levomilnacipran And Vilazodone Data At American College Of Neuropsychopharmacology 53rd Annual Meeting 12/8/2014
Cytokinetics, Inc. (CYTK) Announces Presentations Relating To Tirasemtiv And Effects On Respiratory Muscle Function At International Symposium On ALS/MND 12/8/2014
Geron Corporation (GERN) To Host Analyst And Investor Meeting On December 8 12/8/2014
GTx, Inc. (GTXI) To Present Results On Enobosarm 9mg In Women With Metastatic Breast Cancer At 2014 San Antonio Breast Cancer Symposium 12/8/2014
Seattle Genetics, Inc. (SGEN) Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations In Frontline And Salvage Hodgkin Lymphoma At American Society of Hematology Annual Meeting 12/8/2014
Infinity Pharmaceuticals Inc. (INFI) Reports New Translational Research And Updated Phase 1 Data Of Investigational Oncology Compound Duvelisib At American Society of Hematology Annual Meeting 12/8/2014
H. Lundbeck A/S (LUN.CO) Release: Five-Year Data From SABRIL® (Vigabatrin) Registry Presented At American Epilepsy Society Annual Meeting 12/8/2014
NeuroDerm Ltd. (NDRM) CEO To Present At Oppenheimer Healthcare Conference On December 10, 2014 12/8/2014
Verastem, Inc. (VSTM) Presents Data At The 2014 American Society of Hematology Annual Meeting 12/8/2014
The Medicines Company (MDCO) To Participate In Oppenheimer 25th Annual Healthcare Conference 12/8/2014
Comprehend CEO Rick Morrison Tapped To Present At Xconomy’s Biotech Forum, December 17 12/8/2014
Sorrento Therapeutics, Inc. Announces Poster Presentations On Its Anti-C-Met/PD-L1 Bispecific Antibodies And Anti-C-Met-Antibody Drug Conjugate At The 37th Annual San Antonio Breast Cancer Symposium 12/8/2014
Galena Biopharma  (GALE) To Present HER2 Screening Data From The Phase 3 Neuvax™ (Nelipepimut-S) Clinical Trial At The 2014 San Antonio Breast Cancer Symposium (SABCS) 12/8/2014
Galena Biopharma  (GALE) Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th American Society of Hematology Annual Meeting & Exposition 12/8/2014
Sarah Cannon Research Institute Investigators To Present 16 Abstracts At San Antonio Breast Cancer Symposium 12/8/2014
Sonendo To Present At Bank of America (BAC) Merrill Lynch 2014 Animal & Dental Health Summit 12/8/2014
Orexo Features Positive Results From The ISTART Study At The 2014 AAAP Meeting 12/8/2014
Aptose Biosciences To Present At Oppenheimer 25th Annual Healthcare Conference 12/8/2014
NKT Therapeutics Inc. Presents Data On Its Therapeutic Program Targeting Sickle Cell Disease At The American Society of Hematology 12/8/2014
American Regent, Inc. Announces Clinical Data Presentations At American Society of Hematology 2014 12/8/2014
Sangamo BioSciences, Inc. (SGMO) Presents New Data At American Society of Hematology Meeting Demonstrating Broad Application Of ZFN Mediated Genome-Editing Approach To Therapeutics For Hemophilia And Lysosomal Storage Disorders 12/8/2014
Eisai Inc. (ESALF.PK) Presents New Data On Perampanel And Rufinamide At The 68th Annual American Epilepsy Society Meeting 12/8/2014
Upsher-Smith Laboratories Release: Systematic Review Presented At 68th Annual Meeting Of The American Epilepsy Society Points To Need For Expert Consensus On Seizure Cluster Nomenclature And Diagnosis 12/8/2014
Upsher-Smith Laboratories Presents New Data From Year-Long, Open-Label Extension Study Of Qudexy XR (Topiramate) Extended-Release Capsules At 68th Annual American Epilepsy Society Meeting 12/8/2014
UCB Announces First Presentation Of Primary Data From Latest Phase 3 Study Evaluating Brivaracetam As Adjunctive Treatment Of Partial-Onset Seizures In Epilepsy 12/8/2014
Coherus Biosciences To Present At The J.P. Morgan Healthcare Conference On January 12 12/8/2014
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Date Of Special Meeting In Proposed Merger 12/8/2014
Blueprint Medicines Debuts Comprehensive Preclinical Data Set On First Selective Drug For Patients With Systemic Mastocytosis At 2014 American Society of Hematology Annual Meeting 12/8/2014
Onconova Therapeutics Inc. (ONTX) To Host Analyst Event In New York City On December 12, 2014 12/8/2014
Additional Clinical Data From The Phase 2 Study With Ablynx (ABLYF)'s Anti-vWF Nanobody, Caplacizumab, Presented At The American Society of Hematology Annual Meeting 12/8/2014
Proteon Therapeutics, Inc. (PRTO) To Present At The Oppenheimer 25th Annual Healthcare Conference December 11th 12/8/2014
Keryx Biopharmaceuticals (KERX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014
Foamix Pharmaceuticals, Ltd. (FOMX) To Present Corporate Overview At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014
Onconova Therapeutics Inc. (ONTX) Announces ONTIME Data Presentations At The 2014 American Society of Hematology Annual Meeting 12/8/2014
Affimed Therapeutics AG (AFMD) Presents Final Data For AFM13 Phase 1 Trial At American Society of Hematology 12/8/2014
Lion Biotechnologies, Inc. Announces Positive New Data From Lead TIL Melanoma Program At American Society of Hematology 12/8/2014
Onconova Therapeutics Inc. (ONTX) Announces Data Presentation From Combination Of Rigosertib And Azacitidine In MDS And Non-Proliferative AML At The 2014 American Society of Hematology Annual Meeting 12/8/2014
AbbVie (ABBV) Presents Results from Phase 2 Study Of Investigational Compound Venetoclax (ABT-199/GDC-0199) In Acute Myelogenous Leukemia At The 56th American Society of Hematology Annual Meeting 12/8/2014
Cellerant Therapeutics, Inc. To Present Phase 1 Clinical Data On Evaluation Of CLT-008 In Patients With Acute Myeloid Leukemia At The 2014 American Society of Hematology Annual Meeting 12/8/2014
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Results From Phase 3 VALOR Trial At American Society of Hematology Annual Meeting 12/8/2014
Corbus Pharmaceuticals, Inc. To Present At Oppenheimer 25th Annual Healthcare Conference On December 10, 2014 12/5/2014
NOXXON Pharma AG Release: Phase IIa Results For Spiegelmer Olaptesed Pegol (NOX-A12) In MM And CLL At 2014 American Society of Hematology Conference 12/5/2014
Neurocrine Biosciences, Inc. (NBIX) To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014
Ambit Biosciences And Daiichi Sankyo, Inc. (4568.t) Announce Two Oral Presentations And One Poster Highlighting Quizartinib To Be Presented At The 56th Annual Meeting Of The American Society of Hematology 12/5/2014
Cambrex Corporation (CBM) To Present At Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Crohn's and Colitis Foundation of America Release: IBD Thought Leaders Advances In Inflammatory Bowel Diseases Gather At The Crohn's & Colitis Foundations Clinical & Research Conference 12/5/2014
TrovaGene, Inc. Announces Presentation Of Clinical Data At The 56th American Society of Hematology Annual Meeting 12/5/2014
Pharmacyclics, Inc. (PCYC) Receives 2014 Society For Medicines Research Award For Drug Discovery For Ibrutinib (IMBRUVICA) 12/5/2014
MiMedx To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Organovo To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014
Omnicell Reveals "Take On Tomorrow" Initiative At ASHP Mid-Year Meeting 12/5/2014
Ampio Pharmaceuticals, Inc. (AMPE) To Present At The Oppenheimer Annual Healthcare Conference On December 11th, 2014 12/5/2014
Xencor To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Amgen (AMGN) To Webcast Investor Meeting At Upcoming American Society of Hematology 56th Annual Meeting And Exposition 12/5/2014
Halozyme Therapeutics, Inc. (HALO) To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014
Vaccinex, Inc. To Present Its ActivMAb Antibody Discovery Technology At The 2014 IBC Antibody Engineering & Therapeutics Conference 12/5/2014
Sorrento Therapeutics, Inc. To Present At The 2014 Oppenheimer Healthcare Conference 12/5/2014
Aptose Biosciences To Present Preclinical Research Update For APTO-253 At The 56th American Society of Hematology Annual Meeting 12/5/2014
Relmada Therapeutics Nominated For Buzz Of BIO Contest At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 12/5/2014
ArmaGen Technologies, Inc. To Present At Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Arcturus Therapeutics To Present At The Genetic Rx Boston Biotech Conference 12/5/2014
UCB Reinforces Its Leadership In Epilepsy At The 2014 Annual Meeting Of The American Epilepsy Society 12/5/2014
56th American Society of Hematology Annual Meeting To Highlight Cutting-Edge Research, Celebrate Major Milestones In Hematology 12/5/2014
Stemline Therapeutics, Inc. (STML) Announces Multiple Preclinical Presentations Highlighting Its Pipeline Of IL-3R-Directed Therapeutics At The American Society of Hematology Annual Meeting 12/5/2014
uniQure To Present At The Oppenheimer 25th Healthcare Conference - NYC 12/5/2014
Five Prime Therapeutics, Inc. (FPRX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Ekso Bionics (EKSO) To Host Technology & Development Day 12/5/2014
Hyperion Therapeutics (HPTX) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Karyopharm Therapeutics (KPTI) To Present At Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Amicus Therapeutics, Inc. (FOLD) To Present At Oppenheimer Healthcare Conference 12/5/2014
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The Oppenheimer Healthcare Conference On December 10, 2014 12/5/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Highlights 11 Abstracts At The 56th Annual Meeting Of American Society of Hematology In San Francisco, California, December 6 - 9, 2014 12/5/2014
Immunomedics, Inc. (IMMU) To Present At 25th Annual Oppenheimer Healthcare Conference 12/5/2014
TetraLogic Pharmaceuticals (TLOG) Announces Clinical Data On Birinapant To Be Presented At The 56th Annual American Society of Hematology Annual Meeting 12/5/2014
Zogenix, Inc. (ZGNX) To Participate In Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Cempra Pharmaceuticals, Inc. To Participate In Upcoming Investor Events In December 12/5/2014
Ultragenyx Pharmaceuticals (RARE) To Present At The Oppenheimer Healthcare Conference 12/5/2014
Assembly Biosciences To Present At Investor Conferences 12/5/2014
Relypsa, Inc. (RLYP) To Present At Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Marinus Pharmaceuticals (MRNS) To Present At The Oppenheimer Healthcare Conference 12/5/2014
ADMA Biologics, Inc. To Present At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Adamis Pharmaceuticals (ADMP) To Present At Two Upcoming Conferences 12/5/2014
Protea Biosciences, Inc. To Present At LD Micro Conference 12/5/2014
Progenics Pharmaceuticals, Inc. (PGNX) Announces Presentation At Radiological Society of North America (RSNA) Annual Meeting 12/5/2014
Bio Blast Pharma To Present Corporate Overview At The Oppenheimer 25th Annual Healthcare Conference 12/5/2014
Cortex Pharmaceuticals, Inc. (COR) To Participate In 7th Annual Biotech Showcase 2015(TM) Being Held In San Francisco, California From January 12 - 15, 2015 12/5/2014
Capricor Therapeutics, Inc. Announces Linda Marban, Ph.D. Will Present A Company Overview And Serve As An Expert Panelist At Piper Jaffray's 26th Annual Healthcare Conference 12/5/2014
TetraLogic Pharmaceuticals (TLOG) To Participate In Two Conferences in December 12/5/2014
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call And Slide Webcast Tuesday, December 9 Following Presentation Of Phase 3 12/5/2014
Innate Pharma (IPH.PA ) Announces Its 2015 Financial Calendar As Well As Its Participation In Upcoming Investor Conferences 12/5/2014
Celladon Corporation To Present At 11th Global Cardio Vascular Clinical Trial Forum 12/5/2014
Inogen (INGN) Announces Investor/Analyst Day And Webcast 12/5/2014
Cellular Dynamics International To Present At The Piper Jaffray 26th Annual Healthcare Conference 12/5/2014
StemCells Inc. (STEM) Hosts Leading Biotech Investors And Analysts At Inaugural Event 12/5/2014
Immunomedics, Inc. (IMMU) Announces Outcome Of 2014 Annual Meeting Of Stockholders 12/5/2014
Genentech (RHHBY) To Present Clinical Data From Six Different Medicines At American Society of Hematology Annual Meeting 12/5/2014
BioMarin Pharmaceutical Inc. (BMRN) To Host Analyst And Investor Day On December 10th In New York 12/5/2014
ZIOPHARM Oncology, Inc. (ZIOP.OB) And Intrexon Corporation Present Clinical And Preclinical Data From Immuno-Oncology Programs At Intrexon Corporation Tumor Immunology And Immunotherapy Meeting 12/4/2014
Galectin Therapeutics To Present At 7th Annual LD Micro Main Event Conference 12/4/2014
Auspex Pharmaceuticals To Present At The Piper Jaffray Healthcare Conference 12/4/2014
Heat Biologics To Present At The Piper Jaffray 26th Annual Healthcare Conference On December 2 In New York 12/4/2014
Lion Biotechnologies, Inc. To Present At The Piper Jaffray 26th Annual Healthcare Conference 12/4/2014
Cancer Genetics, Inc. (CGIX) To Present At 26th Annual Piper Jaffray Healthcare Conference 12/4/2014
NeoStem, Inc. And Progenitor Cell Therapy, A Neostem Company, To Present At Multiple December Conferences 12/4/2014
IGI Laboratories, Inc. To Present At Piper Jaffray 26th Annual Healthcare Conference On December 2, 2014 12/4/2014
CytRx Corporation (CYTR) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/4/2014



//-->